Abstract
Data of major clinical trials concerning bone marrow transplantation (BMT) or peripheral blood stem cell transplantation (PBSCT) and treatment with alpha-inter-feron (IFN-α) exist only for patients with chronic myeloid leukemia (CML) and multiple myeloma (MM). Therefore, this contribution is mainly restricted to these two indications. In addition, a brief summary of experimental data on the use of IFN-α for the induction of autologous graft-versus-host disease (GVHD) is given.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Giralt SA, Kantarjian HM, Talpaz M et al (1993) Effect of prior interferon alfa on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemia. J Clin Oncol 11: 1055–1061
Beelen DW, Graeven U, Elmaagacli AH et al (1995) Prolonged administration of interferon alfa in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome. Blood 85: 2981–2990
Higano CS, Raskind WH, Singer JW (1993) Use of interferon alfa-2a to treat hematologic relapse of chronic myelogenous leukemia after bone marrow transplantation. Acta Haematol 89 [Suppl 1]:8–14
Arcese W, Goldman JM, D’Arcangelo E et al (1993) Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Blood 82: 3211–3219
Kolb HJ, Schattenberg A, Goldman JM et al (1995) Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 86: 2041–2050
Cunningham D, Powels R, Malpas JS et al (1993) A randomised trial of maintenance therapy with Intron-A following melphalan and ABMT in myeloma. Proc ASCO 12: 364
Jagannath S, Crowley J, Vesole D et al (1995) Interferon alfa may improve event-free and overall survival in multiple myeloma following double autotransplants. Proc ASCO 14: 425
Harousseau JL, Attal M, Divine M et al (1995) Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French registry on autologous transplantation in multiple myeloma. Blood 85: 3077–385
Ratanatharathorn V, Uberti J, Karanes C et al (1994) Phase I study of alpha-interferon augmentation of cyclosporine-induced graft versus host disease in recipients of autologous bone marrow transplantation. Bone Marrow Transplant 13: 625–630
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Heyll, A., Söhngen, D., Hollmig, K.A., Aul, C. (1997). Alpha-Interferon and Bone Marrow or Peripheral Blood Stem Cell Transplantation. In: Aul, C., Schneider, W. (eds) Interferons. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60411-9_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-60411-9_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-61051-9
Online ISBN: 978-3-642-60411-9
eBook Packages: Springer Book Archive